Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine E Harding

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Brain Pathology (Zurich, Switzerland)|July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSam Loveless, James W Neal, Owain W Howell, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Brain and Behavior|July 22, 2021
Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystoniaMegan E Wadon, Grace A Bailey, Zehra Yilmaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Brain Pathology (Zurich, Switzerland)|July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSam Loveless, James W Neal, Owain W Howell, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Brain and Behavior|July 22, 2021
Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystoniaMegan E Wadon, Grace A Bailey, Zehra Yilmaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Pageof 3